Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with immune-mediated diseases, will hold a conference call on Wednesday, November 14, 2018, at 8:00 a.m
November 5, 2018
· 1 min read